An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR
Description
An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.
Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL
Producer
Latest update
April 21, 2020
License
Creative Commons Attribution 4.0
Metadata quality:
Data description filled
Files documentation missing
License filled
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
All files are available
Metadata quality
Files documentation missing
Update frequency not followed
File formats are closed
Temporal coverage not set
Spatial coverage not set
There are no reuses for this dataset yet.
There are no discussions for this dataset yet.
There are no community resources for this dataset yet.
Information
Tags
License
ID
5e9f437dd2bfb22b625b457e
Temporality
Creation
April 21, 2020
Frequency
Quarterly
Latest update
April 21, 2020